Treating Systemic Juvenile Idiopathic Arthritis with Tocilizumab: Clinical Case

This article describes a case of successfully used tocilizumab (interleukin 6 receptors monoclonal antibodies) in a two-year patient with severe systemic juvenile idiopathic arthritis resistant to oral and parenteral glucocorticoids, nonsteroidal anti-inflammatory drugs, and methotrexate. Just after...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: E. I. Alekseeva, S. I. Valieva, T. M. Bzarova, R. V. Denisova, T. V. Sleptsova, O. L. Lomakina, A. M. Chomakhidze
Formato: Artigo
Idioma:Inglês
Publicado: Paediatrician Publishers, LLC 2016-11-01
Series:Pediatričeskaâ Farmakologiâ
Assuntos:
tocilizumab
juvenile idiopathic arthritis
children
Acceso en liña:https://www.pedpharma.ru/jour/article/view/1447
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares